Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupirtine as Oral Add-on Treatment in Relapsing-Remitting Multiple Sclerosis
2006-005262-39Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in multiple sclerosis (MS) comparing Flupirtine + interferon beta with Placebo + interferon beta (2 arms). Primary endpoints: Incidence of new T2 lesions, Patients without new T2 lesions and 4 more. Started Mar 2007; status: completed.
02
Drugs
flupirtine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-005262-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005262-39.